Buscar

Mostrando ítems 1-10 de 36

Granulocytic Sarcoma Of The Larynx Preceding Chronic Myeloid Leukemia.

Vassallo, J; Altemani, A M; Cardinalli, I A; Crespo, A N; Lima, C S; Eid, K A; Souza, C A (1993)

The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia

Vigorito, AC; Lorand-Metze, I; Chauffaile, MD; Costa, FF; Saad, STO (Vsp BvZeistHolanda, 1998)

Monitoring Of Bcr-abl Levels In Chronic Myeloid Leukemia Patients Treated With Imatinib In The Chronic Phase - The Importance Of A Major Molecular Response.

Machado, Melissa Pereira; Tomaz, Juarez Pires; Lorand-Metze, Irene; de Souza, Cármino Antonio; Vigorito, Afonso Celso; Delamain, Marcia Torresan; Bendit, Israel; Pereira, Noemi Farah; Pagnano, Katia Borgia Barbosa (2011)

BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells

Traina, F; Carvalheira, JBC; Saad, MJA; Costa, FF; Saad, STO (Elsevier Science BvAmsterdamHolanda, 2003)

Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance

SIMÕES, Belinda Pinto; BRAGA JUNIOR, José Wilson Ramos; REGO, Maria Aparecida do Carmo; SOUZA, Cármino Antônio de (Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2011)

Imatinib mesylate was the first BCR-ABL-target agent approved for the treatment of chronic myeloid leukemia. Although most patients respond well to imatinib therapy, the literature shows that one third develops resistance ...

Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: The experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH

Universidade Estadual Paulista (Unesp); Fundação Faculdade Regional de Medicina de São José do Rio Preto; University of Colorado Comprehensive Cancer Center; Faculdade de Medicina de São José do Rio Preto (FAMERP) (2008-07-30)

Investigation of the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia patients is essential to predict prognosis and survival. In 20 patients treated at the Bone Marrow ...

Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: The experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH

Frecuencia de los transcriptos p190BCR-ABL y p210BCR-ABL en una población colombiana con leucemia mieloide crónica (LMC) usando RT-PCR cualitativaDetection of p190BCR-ABL and p210BCR-ABL Fusion Transcripts in Patients with Chronic Myeloid Leukemia (CML) Using Qualitative RT-PCR

Aya Bonilla, Carlos Alberto; Torres Hernandez, José Domingo; Muskus López, Carlos Enrique; Ramírez Gaviria, Gloria Cecilia; Cuervo Sierra, Jorge; Sierra Sánchez, Margarita; Cuéllar Ambrosi, Francisco; Botero Garcés, Jorge Humberto; Artigas A, Carmen Gloria; Muñetón, Carlos Mario; Vásquez Palacio, Gonzalo de Jesús (Universidad de Antioquia, Facultad de MedicinaMedellín, Colombia, 2021)

Detección de mutaciones en el dominio tirosina quinasa de BCR-ABL1 en pacientes colombianos con leucemia mieloide crónica LMC, resistentes al imatinibDetection of BCR-ABL1 Tyrosine Kinase Domain Mutations in Chronic Myeloid Leukaemia Patients with Imatinib Resistance in Colombia

Vásquez Palacio, Gonzalo De Jesús; Ramírez Gaviria, Gloria Cecilia; Muskus López, Carlos Enrique; Torres Hernández, José Domingo; Aya Bonilla, Carlos Alberto (Instituto Nacional de CancerologíaGenética MédicaPrograma de Estudio y Control de Enfermedades Tropicales (PECET)Bogotá, Colombia, 2022)

Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: The experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH

Vendrame-Goloni, C. B.; Carvalho-Salles, A. B.; Ruiz, M. A.; Ricci, O.; Varella-Garcia, M.; Fett-Conte, A. C. (2014)

Buscar

Filtros

Granulocytic Sarcoma Of The Larynx Preceding Chronic Myeloid Leukemia.

The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia

Monitoring Of Bcr-abl Levels In Chronic Myeloid Leukemia Patients Treated With Imatinib In The Chronic Phase - The Importance Of A Major Molecular Response.

BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells

Importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance

Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: The experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH

Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: The experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH

Frecuencia de los transcriptos p190BCR-ABL y p210BCR-ABL en una población colombiana con leucemia mieloide crónica (LMC) usando RT-PCR cualitativaDetection of p190BCR-ABL and p210BCR-ABL Fusion Transcripts in Patients with Chronic Myeloid Leukemia (CML) Using Qualitative RT-PCR

Detección de mutaciones en el dominio tirosina quinasa de BCR-ABL1 en pacientes colombianos con leucemia mieloide crónica LMC, resistentes al imatinibDetection of BCR-ABL1 Tyrosine Kinase Domain Mutations in Chronic Myeloid Leukaemia Patients with Imatinib Resistance in Colombia

Clinical outcome in chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation: The experience of the Bone Marrow Transplantation Unit of FUNFARME/BRAZIL using FISH